tolbutamide has been researched along with Cardiovascular Diseases in 88 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Excerpt | Relevance | Reference |
---|---|---|
"Using nationwide administrative Danish registries, we followed all individuals without prior stroke or myocardial infarction who initiated metformin and an IS from 1997 through 2009." | 3.81 | Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study. ( Andersson, C; Fosbøl, EL; Gislason, G; Køber, L; Mogensen, UM; Scheller, NM; Schramm, TK; Torp-Pedersen, C; Vaag, A, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 79 (89.77) | 18.7374 |
1990's | 2 (2.27) | 18.2507 |
2000's | 2 (2.27) | 29.6817 |
2010's | 4 (4.55) | 24.3611 |
2020's | 1 (1.14) | 2.80 |
Authors | Studies |
---|---|
Sharma, A | 1 |
Pagidipati, NJ | 1 |
Califf, RM | 1 |
McGuire, DK | 1 |
Green, JB | 1 |
Demets, D | 1 |
George, JT | 1 |
Gerstein, HC | 1 |
Hobbs, T | 1 |
Holman, RR | 1 |
Lawson, FC | 1 |
Leiter, LA | 1 |
Pfeffer, MA | 1 |
Reusch, J | 1 |
Riesmeyer, JS | 1 |
Roe, MT | 1 |
Rosenberg, Y | 1 |
Temple, R | 1 |
Wiviott, S | 1 |
McMurray, J | 1 |
Granger, C | 1 |
Douros, A | 1 |
Yin, H | 1 |
Yu, OHY | 1 |
Filion, KB | 1 |
Azoulay, L | 1 |
Suissa, S | 1 |
Bo, S | 1 |
Castiglione, A | 1 |
Ghigo, E | 1 |
Gentile, L | 1 |
Durazzo, M | 1 |
Cavallo-Perin, P | 1 |
Ciccone, G | 1 |
Mogensen, UM | 1 |
Andersson, C | 1 |
Fosbøl, EL | 1 |
Schramm, TK | 1 |
Vaag, A | 1 |
Scheller, NM | 1 |
Torp-Pedersen, C | 1 |
Gislason, G | 1 |
Køber, L | 1 |
Brown, SH | 1 |
Abdelhafiz, AH | 1 |
Abdelmoneim, AS | 1 |
Hasenbank, SE | 1 |
Seubert, JM | 1 |
Brocks, DR | 1 |
Light, PE | 1 |
Simpson, SH | 1 |
Blume, JD | 1 |
Hagenfeldt, L | 1 |
Wahlberg, F | 1 |
Tattersall, RB | 1 |
Ziegelasch, HJ | 1 |
Ziegelasch, H | 1 |
Mauve, L | 1 |
Kilo, C | 2 |
Miller, JP | 2 |
Williamson, JR | 2 |
Lopez-Liuchi, JV | 1 |
Meier, CA | 1 |
Feinglos, MN | 1 |
Bethel, MA | 1 |
Keen, H | 3 |
Jarrett, RJ | 2 |
Fuller, JH | 2 |
Gregory, DR | 1 |
Persson, G | 1 |
Shen, SW | 1 |
Bressler, R | 1 |
Kolata, GB | 1 |
Scott, J | 1 |
Poffenbarger, PL | 1 |
Dippe, SE | 1 |
Sasaki, A | 1 |
Knowles, HC | 1 |
Aarseth, S | 1 |
Ennis, G | 1 |
Bradley, RF | 1 |
Dolger, H | 1 |
Forsham, PH | 1 |
Seltzer, H | 1 |
O'Sullivan, JB | 1 |
D'Agostino, RB | 1 |
Davidson, JK | 1 |
Touber, JL | 1 |
Scoville, AB | 1 |
Williams, RH | 1 |
Palmer, JP | 1 |
Chalmers, TC | 1 |
Moser, RH | 1 |
Moss, JM | 1 |
de Nobel, E | 1 |
van 't Laar, A | 1 |
Bierman, EL | 1 |
Helps, EP | 1 |
Taylor, SH | 1 |
Saxton, C | 1 |
Majid, PA | 1 |
Dykes, JR | 1 |
Ghosh, P | 1 |
Stoker, JB | 1 |
Stowers, JM | 1 |
Clayman, CB | 1 |
Prout, TE | 3 |
Knatterud, GL | 3 |
Meinert, CL | 3 |
Klimt, CR | 3 |
Gray, RH | 1 |
Schor, SS | 1 |
Kirkeby, K | 1 |
Schöffling, K | 1 |
Seltzer, HS | 2 |
Ricketts, HT | 1 |
Finkel, MJ | 1 |
Breidahl, HD | 1 |
Ward, JD | 1 |
Marble, A | 1 |
Feldman, R | 1 |
Crawford, D | 1 |
Elashoff, R | 1 |
Glass, A | 1 |
Folling, I | 1 |
Sotaniemi, EA | 1 |
Huhti, E | 1 |
Fidel, J | 1 |
Nelken, L | 1 |
Lavietes, PH | 1 |
Osborne, RK | 1 |
Martin, DB | 1 |
Schor, S | 1 |
Cornfield, J | 1 |
Salsburg, DS | 1 |
Goetz, FC | 1 |
Nahum, LH | 1 |
Paasikivi, J | 1 |
Canivet, J | 1 |
Deuil, R | 1 |
Eschwege, E | 1 |
Hazard, J | 1 |
Lubetzki, J | 1 |
Tchobroutsky, G | 1 |
Valleron, A | 1 |
Brandman, O | 1 |
Trautwein, H | 1 |
Julitz, R | 1 |
Frey, H | 1 |
Jaiswal, GL | 1 |
Mishra, MP | 1 |
Srivastava, BN | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Prospective, Parallel Goups Study, Aimed to Evaluating Possible Benefits of the Treatment of New Generation Hypoglycaemic Drugs Compared to Sulphonylureas for the Tratment of Type 2 Diabetes Mellitus[NCT04272359] | 138 participants (Anticipated) | Observational [Patient Registry] | 2019-05-06 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for tolbutamide and Cardiovascular Diseases
Article | Year |
---|---|
Trials review: cardiovascular outcome with intensive glycemic control and implications for patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Causality; Comorbidity; Diabetes Complications; | 2009 |
Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Topics: Animals; ATP-Binding Cassette Transporters; Carbamates; Cardiovascular Diseases; Cricetinae; Cyclohe | 2012 |
Likelihood methods for measuring statistical evidence.
Topics: Biometry; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Humans; Hypog | 2002 |
[25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Topics: Aged; Aging; Blood Glucose; Cardiovascular Diseases; Chlorpropamide; Diabetes Complications; Diabete | 1984 |
Therapy for type 2 diabetes: where do we stand after the UK prospective diabetes study?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diet Therapy; Dose-Res | 1999 |
Clinical pharmacology of oral antidiabetic agents (second of two parts).
Topics: Administration, Oral; Cardiovascular Diseases; Chlorpropamide; Clinical Trials as Topic; Diabetes Me | 1977 |
Antidiabetic agents and vascular events.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Di | 1975 |
Oral treatment in diabetes.
Topics: Acetohexamide; Acidosis; Administration, Oral; Animals; Biguanides; Cardiovascular Diseases; Chlorpr | 1972 |
32 trials available for tolbutamide and Cardiovascular Diseases
Article | Year |
---|---|
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Di | 1982 |
The Achilles heel of the University Group Diabetes Program.
Topics: Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes M | 1980 |
The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Diet, Diabetic; Female; Follow | 1980 |
Therapy of type 2 diabetes, cardiovascular death, and the UGDP.
Topics: Angioplasty, Balloon, Coronary; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; D | 1999 |
Letter: Oral hypoglycaemics in diabetes mellitus.
Topics: Adult; Aged; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Male; Mid | 1975 |
Exercise tests in individuals with borderline glucose tolerance and varying smoking habits.
Topics: Aged; Arteriosclerosis; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic | 1977 |
Clinical pharmacology of oral antidiabetic agents (second of two parts).
Topics: Administration, Oral; Cardiovascular Diseases; Chlorpropamide; Clinical Trials as Topic; Diabetes Me | 1977 |
Controversy over study of diabetes drugs continues for nearly a decade.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Drug Information Services; His | 1979 |
Antidiabetic agents and vascular events.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Di | 1975 |
Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
Topics: Administration, Oral; Adult; Aged; Biometry; Cardiovascular Diseases; Clinical Trials as Topic; Diab | 1975 |
"Settling the UGDP controversy"?
Topics: Administration, Oral; Age Factors; Aged; Biometry; Body Weight; Cardiovascular Diseases; Clinical Tr | 1975 |
Decisive factors in the tolbutamide controversy.
Topics: Age Factors; Aged; Analysis of Variance; Biometry; Cardiovascular Diseases; Clinical Trials as Topic | 1975 |
The FDA and hypoglycemic drugs.
Topics: Administration, Oral; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Follow-U | 1975 |
[Heart death and oral antidiabetics; the last judgement].
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Drug Evaluation; Female; Human | 1975 |
The UGDP controversy. Clinical trials versus clinical impressions.
Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; | 1972 |
Tolbutamide. Therapeutic trials and clinical practice.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Evaluation Studies as Top | 1972 |
The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
Topics: Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Diet, Diabetic; | 1973 |
Editorials: Statistical problems in clinical trials: the UGDP study revisited.
Topics: Autopsy; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitu | 1973 |
[Oral therapy in diabetes].
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Humans | 1973 |
Comments on the UGDP study.
Topics: Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypogly | 1974 |
Borderline diabetics and their response to tolbutamide.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diab | 1973 |
[Should the prescription of oral antidiabetic drugs be more limited? Results from controlled clinical trials].
Topics: Aged; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diet, Diabetic; Drug Evalu | 1973 |
Tolbutamide: hazards of leaks.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Diet, Diabetic; Drug Labeling; | 1970 |
Drug fears dismissed.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Societies, Medical; To | 1970 |
A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
Topics: Adult; Age Factors; Aged; Blood Glucose; Body Weight; Cardiovascular Diseases; Cholesterol; Clinical | 1970 |
Controlled clinical trials and the tolbutamide controversy.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Tolbutamide; United St | 1971 |
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
Topics: Age Factors; Aged; Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Compli | 1971 |
The University Group Diabetes Program. A statistician looks at the mortality results.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Diet, Diabetic; Electrocardiog | 1971 |
The University Group Diabetes Program. A further statistical analysis of the mortality findings.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diet, | 1971 |
The UGDP study.
Topics: Aged; Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Diabetic | 1971 |
[Tolbutamide and coronary heart disease].
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Insulin; Lipid | 1971 |
[Attack after oral antidiabetics].
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diet Therapy; Humans; Insulin; Placebos; Tolbutamide | 1970 |
50 other studies available for tolbutamide and Cardiovascular Diseases
Article | Year |
---|---|
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug-Related Side Effects and Adverse Reactions; | 2020 |
Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.
Topics: Aged; Aged, 80 and over; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus | 2017 |
Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confounding Factors, Epidemiol | 2013 |
Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality--a retrospective nationwide study.
Topics: Aged; Carbamates; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Drug Therapy, Combina | 2015 |
Comparison of intravenous glucose tolerance and intravenous tolbutamide response in ischemic cardiovascular disease.
Topics: Adult; Aged; Cardiovascular Diseases; Diabetic Angiopathies; Female; Glucose Tolerance Test; Humans; | 1967 |
[Incidence of pathological ECG findings, hypertension and obesity in diabetic patients depending on their mode of therapy].
Topics: Cardiomegaly; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Electrocardiograph | 1981 |
Oral hypoglycaemics in diabetes mellitus.
Topics: Administration, Oral; Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypoglycemic Agents; Middl | 1975 |
The oral hypoglycemic controversy. Stay as sweet as you are.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetic Ketoacidosis; Drug Evaluation; Humans; Hypoglyc | 1979 |
Tolbutamide pharmacogenetics and the UGDP controversy.
Topics: Alleles; Black People; Cardiovascular Diseases; Diabetes Mellitus; Female; Genes; Humans; Male; Meth | 1979 |
Oral hypoglycemic agents. To use or not use that is the question.
Topics: Administration, Oral; Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypoglycemic Agents; Tolbu | 1979 |
[Evaluation of oral hypoglycemic agents following the University Group of Diabetes Program].
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Tolbutamide | 1977 |
Updating diabetes mellitus. Introduction.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Insulin; Islets of Langerhans Transplantation; P | 1975 |
An historical view of the medical-social aspects of the UGDP.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Hospitals, University; Humans; Mi | 1977 |
[University Group Diabetes Program. The UGDP investigation remains clinically unacceptable].
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus; Humans; Placebos; Research Design; Tolbutamide | 1976 |
A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide.
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic | 1976 |
Oral hypoglycaemic agents--dangers and contraindications.
Topics: Aged; Biguanides; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; L | 1976 |
Oral diabetic drugs again held hazardous.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Tolbutamide | 1975 |
Editorial: Oral hypoglycemic drugs.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diet, Diabetic; Humans; Insulin; Phenformin; Tolbutamide | 1975 |
[Oral antidiabetic drugs].
Topics: Administration, Oral; Cardiovascular Diseases; Diabetes Mellitus; Drug Evaluation; Humans; Sulfonylu | 1975 |
Farewell to phenformin for treating diabetes mellitus.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Insulin; Phenformin; Tolbutamide | 1975 |
Editorial: Settling the UGDP controversy.
Topics: Administration, Oral; Biometry; Cardiovascular Diseases; Costs and Cost Analysis; Diabetes Mellitus; | 1975 |
Editorial: Let's stop the Donnybrook. A perspective on the UGDP-Biometric Society Study.
Topics: Administration, Oral; Adult; Aged; American Medical Association; Biometry; Cardiovascular Diseases; | 1975 |
Letter: The UGDP scandal and cover-up.
Topics: Adult; Aged; Cardiovascular Diseases; Diabetes Mellitus; Drug Evaluation; Female; Humans; Male; Midd | 1975 |
[Letter: Oral antidiabetics and cardiovascular disorders].
Topics: Cardiovascular Diseases; Female; Humans; Hypoglycemic Agents; Middle Aged; Phenformin; Tolbutamide | 1975 |
[Letter: Heart death and oral antidiabetics].
Topics: Cardiovascular Diseases; Female; Humans; Hypoglycemic Agents; Phenformin; Tolbutamide | 1975 |
The tolbutamide controversy.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Phenformin; Tolbutamide; United States | 1975 |
The oral antidiabetic agents.
Topics: Administration, Oral; Adult; Blood Glucose; Body Weight; Cardiovascular Diseases; Diabetes Mellitus; | 1976 |
Tolbutamide.
Topics: Aged; Cardiovascular Diseases; Humans; Hypoglycemia; Insulin; Insulin Secretion; Tolbutamide | 1971 |
The Tolbutamide evidence.
Topics: Administration, Oral; Adult; Age Factors; Cardiovascular Diseases; Diabetes Mellitus; Diet Therapy; | 1971 |
Insulin secretion following myocardial infarction with particular respect to the pathogenesis of cardiogenic shock.
Topics: Adult; Aged; Blood Circulation; Blood Glucose; Cardiovascular Diseases; Catecholamines; Female; Huma | 1969 |
Letter: Tolbutamide revisited.
Topics: Animals; Arrhythmias, Cardiac; Cardiovascular Diseases; Heart; Humans; Hypoglycemic Agents; Phenform | 1974 |
Avoiding the pitfalls of long-term therapeutic trials: lessons learned from the UGDP study.
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diet Therapy; Hum | 1972 |
Tolbutamide and the heart.
Topics: Adenylyl Cyclases; Animals; Cardiovascular Diseases; Diabetes Mellitus; Dose-Response Relationship, | 1972 |
Antilipemic drugs and the position of the FDA.
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Drug Evaluation; Humans; Hypoli | 1972 |
Oral hypoglycaemic agents.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypoglycemic Agents; Male; Phenformin; Tolbutami | 1973 |
Oral hypoglycemic agents.
Topics: Administration, Oral; Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypoglycemic Agents; Tolbu | 1973 |
Therapy of early diabetes. The University Group Diabetes Program.
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diet Therapy; Eva | 1973 |
Vascular disease in diabetes and the effect of oral antidiabetic agents.
Topics: Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Diabetes Mel | 1973 |
Progress report on the prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes: neurovascular studies.
Topics: Adult; Angina Pectoris; Arteries; Blood Glucose; Cardiovascular Diseases; Cerebrovascular Disorders; | 1973 |
Half life of intravenous tolbutamide in the serum of patients in medical wards.
Topics: Adolescent; Adult; Age Factors; Aged; Alcoholic Intoxication; Cardiovascular Diseases; Drug Interact | 1974 |
Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study.
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Chlorpropamide; Diabet | 1974 |
A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diet, Diabetic; Evaluation Studi | 1972 |
Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
Topics: Administration, Oral; Adult; Aged; Attitude of Health Personnel; Cardiovascular Diseases; Diabetes M | 1972 |
Tolbutamide: another view.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Tolbutamide; United States; United States Food a | 1971 |
[Do oral antidiabetics play a part in the cardiovascular mortality of diabetics? Apropos of the University Group Diabetes Program report and the controversies it has raised].
Topics: Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Diet Therapy; Gluc | 1971 |
University group diabetic program and the practicing physician.
Topics: Administration, Oral; Cardiovascular Diseases; Female; Humans; Hypoglycemic Agents; Insulin; Male; T | 1971 |
[Early diagnosis of diabetes mellitus. Results of the intravenous tolbutamide test in 1048 patients].
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Diabetes Mellitus; Female; Germany, West; Glucose | 1969 |
Are antidiabetic drugs dangerous?
Topics: Administration, Oral; Cardiovascular Diseases; Diabetes Complications; Female; Humans; Hypoglycemic | 1970 |
Tolbutamide study raises blood pressures.
Topics: American Medical Association; Boston; Cardiovascular Diseases; Diabetes Mellitus; Diet, Diabetic; In | 1970 |
Effect of tolbutamide in factors producing pain in ischaemic cardio-vascular diseases.
Topics: Adult; Aged; Analgesics; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Tolbutamide | 1969 |